A Genesis HealthCare bankruptcy judge on Tuesday approved the $996 million sale of 01 West State Str…
News
The U.S. Food and Drug Administration has approved Boehringer Ingelheim’s VETMEDIN to delay the onse…
Oviedo Medical Center on Monday announced a $25,000 grant from the HCA Healthcare Foundation to HOPE…
The Food and Drug Administration has delayed reviews of several drugs in a Trump-backed fast-track p…
Boston Scientific acquisition plans include buying Penumbra for about $14.5 billion in a cash-and-st…
AbbVie Inc. is accelerating development of an amylin-based obesity drug licensed from Denmark’s Gubr…
Novo Nordisk says it is refocusing its core business on diabetes and obesity, narrowing diversificat…
Two major studies published Tuesday report that five Minutes of Exercise, such as brisk walking, alo…
The Food and Drug Administration on Sunday announced new manufacturing exemptions for cell and gene …
A bill to extend Affordable Care Act health insurance subsidies advanced in the U.S. House this week…
GSK said Tuesday its experimental hepatitis B drug Bepirovirsen met primary goals in two global phas…
People who stop taking popular weight-loss drugs regain weight rapidly and see heart and diabetes ri…
Researchers at Queens University Belfast are studying how bowel cancer resists chemotherapy, aiming …
Federal health officials on Jan. 5 expanded cervical cancer screening guidelines, allowing women age…
Variant Bio launched its Inference genomic drug discovery platform on Tuesday in Seattle, pairing AI…
US Flu Surge activity across forty-five states, pushing doctor visits to their highest level in near…
Following the New Zealand Medical Data Hack, the government on Monday ordered a review into a cybera…
Novo Nordisk begins 2026 fighting to defend its U.S. weight-loss franchise as lower prices, rising c…
U.S. regulators rejected Corcept Therapeutics’ bid to market Relacorilant for Cushing syndrome–relat…
Millions of patients in England are visiting accident and emergency departments for minor ailments s…